Nani, J. V., Dal Mas, C., Yonamine, C. M., Ota, V. K., Noto, C., Belangero, S. I., . . . Hayashi, M. A. F. (2020). A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone? Int J Neuropsychopharmacol.
Citação norma ChicagoNani, João V., et al. "A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?" Int J Neuropsychopharmacol 2020.
MLA citiranjeNani, João V., et al. "A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?" Int J Neuropsychopharmacol 2020.